Literature DB >> 23772048

Regulation of human class I alcohol dehydrogenases by bile acids.

Cédric Langhi1, Elena Pedraz-Cuesta, Diego Haro, Pedro F Marrero, Joan C Rodríguez.   

Abstract

Class I alcohol dehydrogenases (ADH1s) are the rate-limiting enzymes for ethanol and vitamin A (retinol) metabolism in the liver. Because previous studies have shown that human ADH1 enzymes may participate in bile acid metabolism, we investigated whether the bile acid-activated nuclear receptor farnesoid X receptor (FXR) regulates ADH1 genes. In human hepatocytes, both the endogenous FXR ligand chenodeoxycholic acid and synthetic FXR-specific agonist GW4064 increased ADH1 mRNA, protein, and activity. Moreover, overexpression of a constitutively active form of FXR induced ADH1A and ADH1B expression, whereas silencing of FXR abolished the effects of FXR agonists on ADH1 expression and activity. Transient transfection studies and electrophoretic mobility shift assays revealed functional FXR response elements in the ADH1A and ADH1B proximal promoters, thus indicating that both genes are direct targets of FXR. These findings provide the first evidence for direct connection of bile acid signaling and alcohol metabolism.

Entities:  

Keywords:  ethanol; farnesoid X receptor; gene regulation; liver metabolism

Mesh:

Substances:

Year:  2013        PMID: 23772048      PMCID: PMC3735944          DOI: 10.1194/jlr.M039404

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  43 in total

1.  Gene expression in a young multigene family: tissue-specific differences in the expression of the human alcohol dehydrogenase genes ADH1, ADH2, and ADH3.

Authors:  C J Brown; L Zhang; H J Edenberg
Journal:  DNA Cell Biol       Date:  1996-03       Impact factor: 3.311

2.  Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family.

Authors:  G Duester; J Farrés; M R Felder; R S Holmes; J O Höög; X Parés; B V Plapp; S J Yin; H Jörnvall
Journal:  Biochem Pharmacol       Date:  1999-08-01       Impact factor: 5.858

3.  The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element.

Authors:  Xavier Prieur; Herve Coste; Joan C Rodriguez
Journal:  J Biol Chem       Date:  2003-04-22       Impact factor: 5.157

4.  Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor.

Authors:  Andrew M Anisfeld; Heidi R Kast-Woelbern; Marie E Meyer; Stacey A Jones; Yanqiao Zhang; Kevin J Williams; Timothy Willson; Peter A Edwards
Journal:  J Biol Chem       Date:  2003-03-26       Impact factor: 5.157

5.  Temporal expression of the human alcohol dehydrogenase gene family during liver development correlates with differential promoter activation by hepatocyte nuclear factor 1, CCAAT/enhancer-binding protein alpha, liver activator protein, and D-element-binding protein.

Authors:  C van Ooij; R C Snyder; B W Paeper; G Duester
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

6.  Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer.

Authors:  J Grober; I Zaghini; H Fujii; S A Jones; S A Kliewer; T M Willson; T Ono; P Besnard
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

7.  Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor.

Authors:  Tomoko Nishimaki-Mogami; Mizuho Une; Tomofumi Fujino; Yoji Sato; Norimasa Tamehiro; Yosuke Kawahara; Koichi Shudo; Kazuhide Inoue
Journal:  J Lipid Res       Date:  2004-05-16       Impact factor: 5.922

8.  Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.

Authors:  Inés Pineda Torra; Thierry Claudel; Caroline Duval; Vladimir Kosykh; Jean-Charles Fruchart; Bart Staels
Journal:  Mol Endocrinol       Date:  2003-02

9.  Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways.

Authors:  I A Pikuleva; A Babiker; M R Waterman; I Björkhem
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

10.  Redundant pathways for negative feedback regulation of bile acid production.

Authors:  Li Wang; Yoon-Kwang Lee; Donnie Bundman; Yunqing Han; Sundararajah Thevananther; Chang Soo Kim; Steven S Chua; Ping Wei; Richard A Heyman; Michael Karin; David D Moore
Journal:  Dev Cell       Date:  2002-06       Impact factor: 12.270

View more
  8 in total

Review 1.  The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation.

Authors:  Li Di; Amanda Balesano; Samantha Jordan; Sophia M Shi
Journal:  AAPS J       Date:  2021-01-07       Impact factor: 4.009

2.  Enhanced ethanol catabolism in orphan nuclear receptor SHP-null mice.

Authors:  Jung Eun Park; Mikang Lee; Ryan Mifflin; Yoon Kwang Lee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-11       Impact factor: 4.052

Review 3.  New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease.

Authors:  Yali Liu; Tao Liu; Xu Zhao; Yanhang Gao
Journal:  Cell Mol Life Sci       Date:  2022-08-17       Impact factor: 9.207

4.  Role of the pregnane X receptor in binge ethanol-induced steatosis and hepatotoxicity.

Authors:  Sora Choi; Afua A Gyamfi; Prince Neequaye; Samuel Addo; Frank J Gonzalez; Maxwell A Gyamfi
Journal:  J Pharmacol Exp Ther       Date:  2018-02-05       Impact factor: 4.030

5.  Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver.

Authors:  Deepak Kumar Bhatt; Andrea Gaedigk; Robin E Pearce; J Steven Leeder; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2017-06-12       Impact factor: 3.922

6.  Microarray Analysis of Differentially-Expressed Genes Encoding CYP450 and Phase II Drug Metabolizing Enzymes in Psoriasis and Melanoma.

Authors:  Venil N Sumantran; Pratik Mishra; Rakesh Bera; Natarajan Sudhakar
Journal:  Pharmaceutics       Date:  2016-02-17       Impact factor: 6.321

7.  Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures.

Authors:  Robim M Rodrigues; Laxmikanth Kollipara; Umesh Chaudhari; Agapios Sachinidis; René P Zahedi; Albert Sickmann; Annette Kopp-Schneider; Xiaoqi Jiang; Hector Keun; Jan Hengstler; Marlies Oorts; Pieter Annaert; Eef Hoeben; Eva Gijbels; Joery De Kock; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2018-05-14       Impact factor: 5.153

Review 8.  Role of farnesoid X receptor and bile acids in alcoholic liver disease.

Authors:  Sharon Manley; Wenxing Ding
Journal:  Acta Pharm Sin B       Date:  2015-03-09       Impact factor: 11.413

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.